Gene expression profiling studies for breast cancer have unveiled that breast cancer has very heterogeneous biological characteristics and at least four molecular distinct subtypes, such as luminal A and B, human epidermal growth factor receptor2 (HER2)-enriched, and basal-like subtypes have been identified over the few last decades [1–3]. Here, ERBB2 is linked to breast carcinoma.